Compare DBD & EXPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DBD | EXPO |
|---|---|---|
| Founded | 1859 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Professional Services |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2023 | 1996 |
| Metric | DBD | EXPO |
|---|---|---|
| Price | $85.37 | $62.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $90.00 | $88.00 |
| AVG Volume (30 Days) | 316.1K | ★ 604.4K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.87% |
| EPS Growth | ★ 677.27 | N/A |
| EPS | 0.14 | ★ 0.59 |
| Revenue | ★ $3,805,700,000.00 | $582,014,000.00 |
| Revenue This Year | $3.56 | $12.75 |
| Revenue Next Year | $3.25 | $8.50 |
| P/E Ratio | $609.00 | ★ $105.25 |
| Revenue Growth | 1.46 | ★ 4.21 |
| 52 Week Low | $53.93 | $51.91 |
| 52 Week High | $89.05 | $81.95 |
| Indicator | DBD | EXPO |
|---|---|---|
| Relative Strength Index (RSI) | 60.79 | 60.86 |
| Support Level | $73.05 | $54.15 |
| Resistance Level | $89.05 | $69.49 |
| Average True Range (ATR) | 2.84 | 2.01 |
| MACD | -0.02 | 0.52 |
| Stochastic Oscillator | 70.00 | 86.72 |
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment.
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.